Final Program

SATURDAY • MAY 14 23
Chairing: N.C. Netzer, MD, PhD, Bad Aibling, Germany
C. Marcus, MBBCh, Philadelphia, PA
8:00 Introduction
N.C. Netzer, MD, PhD, Bad Aibling, Germany
Part One: Central Apnea Physiology
8:05 Rhytmogenesis and Loop Gain as Unifying Mechanisms of
Periodic Central Apneas
S.A. Sands, PhD, Boston, MA
8:35 Upper Airway Physiology and Central Apneas: The
Neuromechanical Interface
D.J. Eckert, PhD, Sydney, Australia
9:05 Brain and Carotid Body Sensors Involved in Generating
Central Apneas
J. Neubauer, PhD, New Brunswick, NJ
9:35 Hypoxia Provoked Periodic Breathing During Sleep: A Model
for CSR?
N.C. Netzer, MD, PhD, Bad Aibling, Germany
10:05 Panel Discussion
K.P. Strohl, MD, Cleveland, OH
D.J. Eckert, PhD, Sydney, Australia
10:30 Break
Part Two: Clinical Aspects and Treatment of Central
Breathing Disorders
10:45 The ERS Task Force Consensus on Central Apneas
W. Randerath, MD, Solingen, Germany
11:20 Central Apneas in Infants and Children. When to Worry and
How to Treat
C. Marcus, MBBCh, Philadelphia, PA
11:55 Central Apneas in the Geriatric Patient: A Buddy of Aging
M. Morrell, MD, PhD, London, United Kingdom
12:30 LUNCH
1:15 Role of Phrenic Nerve Stimulation and Cardiac Pacing in the
Treatment of CA in Heart Failure
M. Arzt, MD, Regensburg, Germany
1:45 In Patients with Heart Failure, Should We Concentrate on
Treating the Obstructive Events? What the SERVE HF Study
Taught Us
H. Woehrle, MD, Blaubeuren, Germany
2:15 SERVE HF Is Not the Only Truth. What We Learned from the
ADVENT-HF Study
D. Bradley, MD, Toronto, Canada
2:45 Break
3:00 Devil or Saint? Supplemental Oxygen Treatment in Central
Breathing Disorders Including CSA in Stroke
C. Roffe, PhD, Stoke on Trent, United Kingdom
3:30 Panel Discussion
C. Marcus, MBBCh, Philadelphia, PA
D. Bradley, MD, Toronto, Canada
BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL
POSTGRADUATE COURSE
CME Credits Available: 6.5
PG27 LUNG CANCER: STATE OF THE ART IN 2016
Pre-registration and additional fees required. Continental breakfast and
box lunch included. Attendance is limited.
Member: $350 In-Training Member: $200
Non-Member: $425 In-Training Non-Member: $300
Registrants must bring a laptop to the
course to view the course material.
Assemblies on Thoracic Oncology; Behavioral Science and Health Services
Research; Clinical Problems; Respiratory Cell and Molecular Biology
8:00 a.m. - 3:35 p.m. MOSCONE CENTER
Room 2011 (West Building, Level 2)
Target Audience
All providers caring for patients with lung nodules, lung cancer. This includes
pulmonologists, thoracic surgeons, radiation oncologists, nurse practitioners
and physician assistants.
Objectives
At the conclusion of this session, the participant will be able to:
• describe the benefits and risks of lung cancer screening;
• explain the roles that surgery and stereotactic body radiation therapy have for
patients with early NSCLC;
• describe the recent advances in molecular medicine as it relates to lung cancer.
This course will provide a comprehensive review of topics in the evaluation and
management of patients with lung cancer including risk assessment and screening, the
approach to pulmonary nodules, and the importance of molecular characterization of
lung cancer. In addition, we will discuss treatment options for early stage and locally
advanced NSCLC, the role in interventional pulmonology and palliative care in the
management of patients with lung cancer and disparities in lung cancer burden,
evaluation and treatment. Novel diagnostic tools and treatment modalities including
biomarkers /genomic classifiers and immunomodulating therapies. The importance of
tobacco cessation programs and tobacco control will also be discussed. Interactive
tumor boards will be held to highlight main teaching points.
Chairing: D.J. Feller-Kopman, MD, Baltimore, MD
M.P. Rivera, MD, Chapel Hill, NC
8:00 Introduction
D.J. Feller-Kopman, MD, Baltimore, MD
8:05 Tobacco and E-Cigarettes: Control or Out of Control?
A. Vachani, MD, MS, Philadelphia, PA
8:30 Lung Cancer Screening: Who, Why and How
N.T. Tanner, MD, MSCR, Charleston, SC
8:55 The Role of Advanced Diagnostic Bronchoscopy in the
Diagnosis and Staging of Lung Cancer
J.A. Akulian, MD, MPH, Chapel Hill, NC
9:20 Tumor Board
D.J. Feller-Kopman, MD, Baltimore, MD
9:55 Break
SATURDAY
ATS 2016 • San Francisco